Sign inGet started

Cohlhepp Ryan

Insider CIK 2034665 · BCAX President, COO & Interim CEO, Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
BCAX Bicara Therapeutics Inc. M Exercise deriv2026-09-082026-09-1017,500— $034,252SEC↗
BCAX Bicara Therapeutics Inc. M Exercise2026-09-082026-09-1017,500$3.79 $66.3K199,141SEC↗
BCAX Bicara Therapeutics Inc. S Sale2026-09-082026-09-1014,058$22.77 $320.1K185,083SEC↗
BCAX Bicara Therapeutics Inc. S Sale2026-09-082026-09-103,442$23.43 $80.6K181,641SEC↗
BCAX Bicara Therapeutics Inc. M Exercise deriv2026-09-082026-09-1017,500— $034,252SEC↗
BCAX Bicara Therapeutics Inc. S Sale2026-09-082026-09-103,442$23.43 $80.7K181,641SEC↗
BCAX Bicara Therapeutics Inc. S Sale2026-09-082026-09-1014,058$22.77 $320.1K185,083SEC↗
BCAX Bicara Therapeutics Inc. M Exercise2026-09-082026-09-1017,500$3.79 $66.3K199,141SEC↗
BCAX Bicara Therapeutics Inc. M Exercise deriv2026-08-102026-08-1218,750— $051,752SEC↗
BCAX Bicara Therapeutics Inc. S Sale2026-08-102026-08-1218,750$27.98 $524.6K181,641SEC↗
BCAX Bicara Therapeutics Inc. M Exercise2026-08-102026-08-1218,750$3.79 $71.1K200,391SEC↗
BCAX Bicara Therapeutics Inc. M Exercise deriv2026-08-102026-08-1218,750— $051,752SEC↗
BCAX Bicara Therapeutics Inc. S Sale2026-08-102026-08-1218,750$27.98 $524.5K181,641SEC↗
BCAX Bicara Therapeutics Inc. M Exercise2026-08-102026-08-1218,750$3.79 $71.1K200,391SEC↗
BCAX Bicara Therapeutics Inc. S Sale2026-07-092026-07-10536$29.00 $15.5K181,641SEC↗
BCAX Bicara Therapeutics Inc. M Exercise deriv2026-07-082026-07-1018,750— $070,502SEC↗
BCAX Bicara Therapeutics Inc. S Sale2026-07-082026-07-104,306$29.80 $128.3K183,252SEC↗
BCAX Bicara Therapeutics Inc. S Sale2026-07-082026-07-101,075$30.35 $32.6K182,177SEC↗
BCAX Bicara Therapeutics Inc. S Sale2026-07-082026-07-1022,833$28.76 $656.7K187,558SEC↗
BCAX Bicara Therapeutics Inc. M Exercise2026-07-082026-07-1018,750$3.79 $71.1K210,391SEC↗
BCAX Bicara Therapeutics Inc. M Exercise deriv2026-05-152026-05-188,000— $0101,334SEC↗
BCAX Bicara Therapeutics Inc. S Sale2026-05-152026-05-184,500$20.29 $91.3K191,641SEC↗
BCAX Bicara Therapeutics Inc. S Sale2026-05-152026-05-188,000$20.29 $162.3K196,141SEC↗
BCAX Bicara Therapeutics Inc. M Exercise2026-05-152026-05-188,000$3.79 $30.3K204,141SEC↗
BCAX Bicara Therapeutics Inc. M Exercise deriv2026-04-152026-04-178,000— $0109,334SEC↗
BCAX Bicara Therapeutics Inc. M Exercise2026-04-152026-04-178,000$3.79 $30.3K208,641SEC↗
BCAX Bicara Therapeutics Inc. S Sale2026-04-152026-04-178,000$23.01 $184.1K200,641SEC↗
BCAX Bicara Therapeutics Inc. S Sale2026-04-152026-04-174,500$23.01 $103.5K196,141SEC↗
BCAX Bicara Therapeutics Inc. M Exercise deriv2026-03-162026-03-178,000— $0117,334SEC↗
BCAX Bicara Therapeutics Inc. M Exercise2026-03-162026-03-178,000$3.79 $30.3K213,141SEC↗
BCAX Bicara Therapeutics Inc. S Sale2026-03-162026-03-174,500$19.66 $88.5K200,641SEC↗
BCAX Bicara Therapeutics Inc. S Sale2026-03-162026-03-178,000$19.66 $157.3K205,141SEC↗
BCAX Bicara Therapeutics Inc. M Exercise deriv2026-03-032026-03-0512,892— $0125,334SEC↗
BCAX Bicara Therapeutics Inc. S Sale2026-03-032026-03-054,500$18.16 $81.7K205,141SEC↗
BCAX Bicara Therapeutics Inc. M Exercise2026-03-032026-03-0512,892$3.79 $48.9K222,533SEC↗
BCAX Bicara Therapeutics Inc. S Sale2026-03-032026-03-0512,892$18.16 $234.1K209,641SEC↗
BCAX Bicara Therapeutics Inc. M Exercise deriv2026-02-252026-02-273,108— $0138,226SEC↗
BCAX Bicara Therapeutics Inc. S Sale2026-02-252026-02-27523$18.04 $9.4K209,641SEC↗
BCAX Bicara Therapeutics Inc. S Sale2026-02-252026-02-273,108$18.04 $56.1K210,164SEC↗
BCAX Bicara Therapeutics Inc. M Exercise2026-02-252026-02-273,108$3.79 $11.8K213,272SEC↗
BCAX Bicara Therapeutics Inc. A Award deriv2026-02-022026-02-04300,000— $0300,000SEC↗
BCAX Bicara Therapeutics Inc. S Sale2026-01-222026-01-263,828$18.10 $69.3K210,164SEC↗
BCAX Bicara Therapeutics Inc. S Sale2026-01-152026-01-20149$18.02 $2.7K213,992SEC↗
BCAX Bicara Therapeutics Inc. M Exercise deriv2025-12-262025-12-2925,000— $039,909SEC↗
BCAX Bicara Therapeutics Inc. M Exercise2025-12-262025-12-2925,000$4.44 $111.0K214,141SEC↗
BCAX Bicara Therapeutics Inc. M Exercise deriv2025-12-152025-12-168,000— $0141,334SEC↗
BCAX Bicara Therapeutics Inc. M Exercise2025-12-152025-12-168,000$3.79 $30.3K201,641SEC↗
BCAX Bicara Therapeutics Inc. S Sale2025-12-152025-12-168,000$18.68 $149.4K193,641SEC↗
BCAX Bicara Therapeutics Inc. S Sale2025-12-152025-12-164,500$18.68 $84.1K189,141SEC↗
BCAX Bicara Therapeutics Inc. M Exercise deriv2025-11-212025-11-258,000— $0149,334SEC↗
BCAX Bicara Therapeutics Inc. S Sale2025-11-212025-11-258,000$18.05 $144.4K198,141SEC↗
BCAX Bicara Therapeutics Inc. S Sale2025-11-212025-11-254,500$18.05 $81.2K193,641SEC↗
BCAX Bicara Therapeutics Inc. M Exercise2025-11-212025-11-258,000$3.79 $30.3K206,141SEC↗
BCAX Bicara Therapeutics Inc. M Exercise deriv2025-10-152025-10-168,000— $0157,334SEC↗
BCAX Bicara Therapeutics Inc. M Exercise2025-10-152025-10-168,000$3.79 $30.3K210,641SEC↗
BCAX Bicara Therapeutics Inc. S Sale2025-10-152025-10-164,500$18.16 $81.7K198,141SEC↗
BCAX Bicara Therapeutics Inc. S Sale2025-10-152025-10-168,000$18.16 $145.3K202,641SEC↗
BCAX Bicara Therapeutics Inc. M Exercise deriv2025-10-072025-10-088,000— $0165,334SEC↗
BCAX Bicara Therapeutics Inc. M Exercise2025-10-072025-10-088,000$3.79 $30.3K213,541SEC↗
BCAX Bicara Therapeutics Inc. S Sale2025-10-072025-10-088,000$18.06 $144.5K205,541SEC↗
BCAX Bicara Therapeutics Inc. S Sale2025-10-072025-10-082,900$18.06 $52.4K202,641SEC↗
BCAX Bicara Therapeutics Inc. M Exercise deriv2025-10-062025-10-0824,000— $0173,334SEC↗
BCAX Bicara Therapeutics Inc. M Exercise2025-10-062025-10-0824,000$3.79 $91.0K245,141SEC↗
BCAX Bicara Therapeutics Inc. S Sale2025-10-062025-10-0824,000$18.06 $433.4K221,141SEC↗
BCAX Bicara Therapeutics Inc. S Sale2025-10-062025-10-0815,600$18.06 $281.7K205,541SEC↗